EGCG (Epigallocatechin Gallate) Side Effects

Reported EGCG (Epigallocatechin Gallate) side effects

EGCG safety is characterized by an excellent safety record at dietary and moderate supplementation doses but with specific hepatotoxicity concerns at high concentrated supplementation doses that require careful understanding. Gastrointestinal effects (most common): Mild stomach upset, nausea, constipation, or diarrhea occur in 5-15% of supplement users. Worse with fasted administration; take with food to minimize. Caffeine content of non-decaffeinated products contributes to some GI effects. Hepatotoxicity (most serious, dose-dependent): The primary serious safety concern with EGCG. Concentrated high-dose EGCG supplements (particularly >800 mg daily, fasted, or in susceptible individuals) can cause liver enzyme elevations and rarely severe hepatitis. EFSA 2018 systematic review established 800 mg daily as the upper safety threshold for supplementary EGCG. Case reports describe acute hepatitis with jaundice, liver enzyme elevations to 1000-5000 U/L, and rarely progression to liver failure. Most cases resolve with discontinuation but some have required liver transplantation. Risk factors include: high doses (>800 mg/day), fasted administration, combination with other hepatotoxic substances (alcohol, some medications), individual susceptibility (possibly genetic polymorphisms), weight loss products containing concentrated EGCG. Green tea beverage consumption at dietary levels (1-8 cups daily) is not associated with hepatotoxicity. Practical guidance: limit supplemental EGCG to 400-500 mg daily for most users, take with food, avoid fasted state, monitor liver function if using >500 mg daily, discontinue immediately if symptoms of jaundice, dark urine, or severe fatigue develop. Iron absorption interference: EGCG chelates iron and reduces non-heme iron absorption substantially (up to 50% reduction when taken with iron-containing meals). Clinically significant in individuals with borderline iron status, menstruating women, vegetarians, frequent blood donors, or those with iron deficiency anemia. Take EGCG separately from iron-containing meals (at least 1 hour apart) if iron status is a concern. Some individuals may develop iron deficiency with chronic high-dose EGCG use. Caffeine-related effects (non-decaffeinated products): Green tea contains caffeine (approximately 20-40 mg per cup, up to 100+ mg per high-dose extract). Caffeine-related effects include jitteriness, anxiety, insomnia, heart palpitations, and headache in sensitive individuals. Decaffeinated products (Teavigo, decaf green tea extract) eliminate these effects. Headache: Mild headache is reported occasionally, often resolving with continued use or dose reduction. Sleep disruption: Evening EGCG consumption (particularly of caffeinated forms) can disrupt sleep in caffeine-sensitive individuals. Anxiety and palpitations: Caffeine content of green tea extracts can produce anxiety and palpitations in sensitive individuals, particularly at high doses. Drug interactions: Warfarin: Green tea contains vitamin K and may reduce warfarin effectiveness; EGCG itself has mild antiplatelet activity. Consistent green tea intake is manageable with warfarin dose adjustment; high-dose supplementation is less predictable. Iron-containing medications/supplements: EGCG reduces iron absorption. Stimulants (caffeine, amphetamines, decongestants): Additive caffeine effects if EGCG product contains caffeine. Antihypertensives: Theoretical additive blood pressure reduction. Nadolol and some beta-blockers: Green tea reduces nadolol bioavailability; avoid high-dose green tea extract with nadolol. Aspirin and NSAIDs: Additive antiplatelet effects at high EGCG doses. Cisplatin and some chemotherapy agents: Potential reduction of anticancer effect (case reports); discuss with oncology team. MAO inhibitors: Theoretical interaction via COMT inhibition and catecholamine potentiation. Pregnancy: High-dose EGCG has been associated with neural tube defects in animal models through folate antagonism. Pregnant women should avoid high-dose EGCG supplementation. Dietary green tea consumption (1-2 cups daily) is generally considered safe during pregnancy. Lactation: Green tea beverage consumption is compatible with breastfeeding in moderate amounts. High-dose supplementation should be avoided. Pediatric use: Pediatric EGCG supplementation is generally not recommended due to hepatotoxicity concerns. Dietary green tea may be consumed by older children in moderate amounts. Anxiety and mood: Some users report anxiety or mood changes with high-dose EGCG, particularly caffeinated forms. Mucosal irritation: Topical EGCG preparations (e.g., for genital HPV lesions) can cause local irritation, redness, or burning sensation. Allergic reactions: Rare but possible with green tea allergy. Blood glucose effects: EGCG lowers blood glucose modestly. Diabetic patients on insulin or sulfonylureas should monitor for hypoglycemia. Overall tolerability grade: Excellent at dietary levels (green tea beverage consumption 1-5 cups daily) and good at moderate supplementation (200-400 mg EGCG daily taken with food). Caution required at high supplementation doses (>500 mg/day) with specific attention to hepatotoxicity, iron deficiency, and medication interactions. The hepatotoxicity concern is real but dose-dependent and largely avoidable with appropriate dose selection and with-food administration.

When to continue, reduce, or stop EGCG (Epigallocatechin Gallate)

EGCG (Epigallocatechin Gallate) contraindications

Absolute contraindications: Pre-existing severe hepatic impairment: Avoid high-dose EGCG supplementation; dietary green tea may be acceptable with clinician guidance. Pregnancy (high-dose supplementation): Neural tube defect concerns from animal studies; limit to dietary green tea consumption. Known allergy to green tea or catechins: Rare but possible. Concurrent use of nadolol: Green tea/EGCG reduces nadolol bioavailability substantially; avoid combination. Relative contraindications (discuss with physician before use): Chronic alcohol use: Additive hepatotoxic potential; reduce or avoid high-dose EGCG supplementation. Concurrent use of acetaminophen at therapeutic or toxic doses: Potential hepatotoxic interaction. Iron deficiency anemia: EGCG reduces iron absorption; separate timing or avoid high doses. Anticoagulation therapy (warfarin): Vitamin K content of green tea interferes with warfarin; inconsistent green tea consumption is problematic. Active cancer under chemotherapy: Some chemotherapy drug interactions documented; oncology team consultation required. Cardiovascular arrhythmia with caffeine sensitivity: Use decaffeinated products only. Severe anxiety or insomnia: Avoid caffeinated green tea extract, particularly in evening. Pre-existing liver enzyme elevations: Obtain hepatology clearance before high-dose supplementation. Kidney disease: No specific contraindication but use at lower doses. Upcoming surgical procedures: Discontinue EGCG supplementation 7-10 days before surgery due to mild antiplatelet effects. Caution populations: Adults over 75 years: Start at lower doses; monitor liver function more frequently. Polypharmacy users: Multiple drug interactions possible via CYP modulation; physician awareness. Pregnant women with folate deficiency concerns: Ensure adequate folate; avoid high-dose EGCG. Iron-deficient populations (menstruating women, vegetarians, frequent blood donors): Monitor iron status. Drug interactions requiring monitoring: Warfarin and other anticoagulants (vitamin K and antiplatelet considerations) Iron-containing medications/supplements Nadolol and some beta-blockers Aspirin and NSAIDs (additive antiplatelet) Stimulants (additive caffeine effects if caffeinated form) MAO inhibitors (theoretical catecholamine effects) Some chemotherapy agents (cisplatin, bortezomib, tyrosine kinase inhibitors) Lithium (theoretical reduction through diuresis) Discontinue immediately and seek medical attention if: Jaundice (yellowing of skin or eyes) Dark urine or pale stools Severe fatigue or weakness Abdominal pain in the right upper quadrant Severe nausea and vomiting Signs of hepatic dysfunction Significant unexplained bleeding or bruising Severe allergic reaction

Why vendor quality drives EGCG (Epigallocatechin Gallate) side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

EGCG (Epigallocatechin Gallate) side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .